INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR NONMUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER - PATTERNS OF USE, AND IMPACT ON OUTCOMES

被引：0
|
作者：
Azer, S. [1 ]
Ranasinghe, W. [2 ]
Webb, C. [1 ]
Lioufas, P. A. [2 ]
Cetti, R. [2 ]
Frydenberg, M. [2 ,3 ]
Bolton, D. [1 ,4 ]
Appu, S. [2 ,3 ]
Sengupta, S. [1 ,4 ]
机构：
[1] Austin Hlth, Dept Urol, Melbourne, Vic, Australia
[2] Monash Med Ctr, Dept Urol, Melbourne, Vic, Australia
[3] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia
[4] Univ Melbourne, Austin Dept Surg, Melbourne, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 11卷
关键词：
Bacillus Calmette-Guerin; urothelial carcinoma; nonmuscle invasive bladder cancer; prognostic factors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [21] Does the strain of bacillus calmette-guerin (BCG) used for intravesical instillations in the treatment of nonmuscle invasive transitional cell carcinoma of the bladder matter?
    Thalmann, George N.
    Birkhaeuser, Frederic
    Rentsch, Cyrill A.
    Ochsner, Katharina
    Studer, Urs E.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 522 - 522
  • [22] UTILIZATION OF INITIAL CYSTECTOMY VERSUS INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR NON-MUSCLE INVASIVE MICROPAPILLARY UROTHELIAL CARCINOMA OF THE BLADDER
    Gupta, Karishma
    Omil-Lima, Danly
    Chen, Lin
    Muncey, Wade
    Lengu, Irma
    Scarberry, Kyle
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E297 - E297
  • [23] Utilization of Bacillus Calmette- Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages REPLY
    Khanna, Abhinav
    Abouassaly, Robert
    [J]. UROLOGY, 2019, 124 : 126 - 126
  • [24] A Prospective Comparative Study of Intravesical Bacillus Calmette-Guerin Therapy with the Tokyo or Connaught Strain for Nonmuscle Invasive Bladder Cancer
    Sengiku, Atsushi
    Ito, Masaaki
    Miyazaki, Yu
    Sawazaki, Harutake
    Takahashi, Takeshi
    Ogura, Keiji
    [J]. JOURNAL OF UROLOGY, 2013, 190 (01): : 50 - 54
  • [25] Emerging Immunotherapy Options for bacillus Calmette-Guerin Unresponsive Nonmuscle Invasive Bladder Cancer
    Meng, Maxwell V.
    Gschwend, Juergen E.
    Shore, Neal
    Grossfeld, Gary D.
    Mostafid, Hugh
    Black, Peter C.
    [J]. JOURNAL OF UROLOGY, 2019, 202 (06): : 1111 - 1119
  • [26] Intravesical Bacillus Calmette-Guerin Outcomes in Patients With Bladder Cancer and Asymptomatic Bacteriuria
    Herr, Harry W.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (02): : 435 - 437
  • [27] IMPACT OF PRIOR INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER ON THE EFFICACY OF PEMBROLIZUMAB IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA
    Taoka, Rikiya
    Kobayashi, Takashi
    Hidaka, Yu
    Abe, Hiroyasu
    Morita, Satoshi
    Ogawa, Osamu
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Sugimoto, Mikio
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E22 - E22
  • [28] Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guerin Therapy
    Barlow, LaMont J.
    McKiernan, James M.
    Benson, Mitchell C.
    [J]. JOURNAL OF UROLOGY, 2013, 189 (03): : 834 - 839
  • [29] Should intravesical Bacillus Calmette-Guerin be employed in transplant recipients with bladder carcinoma?
    Sun, H. -Y.
    Singh, N.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (04) : 358 - 362
  • [30] Bacillus calmette-guerin (BCG) used for intravesical instillations in the treatment of nonmuscle invasive transitional cell carcinoma (TCC) of the bladder: Does the strain matter?
    Thalmann, G. N.
    Birkhaeuser, F.
    Rentsch, C. A.
    Ochsner, K.
    Studer, U. E.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 61 - 61
12345